Hester Biosciences informs about submission of audited standalone financial results

08 May 2017 Evaluate

Hester Biosciences has informed about Submission of Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31 March 2017.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1262.65 -56.30 (-4.27%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×